Polygonum cuspidatum stem extract (PSE) ameliorates dry eye disease by inhibiting inflammation and apoptosis

다국어 초록 (Multilingual Abstract)

[Purpose] Here, we aimed to determine the effect of Polygonum cuspidatum stem extract (PSE) on exorbital lacrimal gland-excised rat models and hyperosmotic stress-stimulated human conjunctival cells (HCCs).
[Methods] Seven week old male Wistar rats were divided into six groups. Only the rats in the control group (NOR, n=5) did not undergo surgery. Three days after the surgery, the exorbital lacrimal gland-excised rats were randomly allocated to five groups: (1) vehicle-treated dry-eyed rats (DED, n=5); (2) PSE (10mg/kg) treated DED rats (PSE-10, n=5); (3) PSE (100mg/kg) treated DED rats (PSE-100, n=5); and (4) PSE (250mg/kg) treated DED rats (PSE-250, n=5). In addition, the HCC line was co-treated with hyperosmolar media (528 mOsm) and PSE (1-100μg/ml).
[Results] PSE treatment restored the tear volume and goblet cell density by inhibiting severe corneal irregularities and damage. The treatment with PSE significantly attenuated the hyperosmolar stress-induced inflammation and cell death through the suppression of mRNA expression levels of Tumor necrosis factor-α (TNF-α), Interleukin-6 (IL-6), Interleukin-1β (IL-1β), and Interferon-γ (IFN-γ), and the expression of Bcl-2-associated X protein (Bax) as well as the activation of caspase-3 in vitro.
[Conclusion] The inhibitory effects of PSE treatment on dry eye disease indicate the potential of nutritional intervention by PES against inflammatory diseases without adverse effects.

참고문헌 (Reference)

• 1 Kim YS, "Volatile constituents from the leaves of Polygonum cuspidatum S. et Z. and their anti-bacterial activities" 22 : 139-144, 2005
• 2 Ratay ML, "Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease" 258 : 208-217, 2017
• 3 Zhu YP, "Traditional Chinese herbal medicine" 17 : 103-112, 1995
• 4 Bralley EE, "Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation" 5 : 1-, 2008
• 5 Fraunfelder FT, "The role of medications in causing dry eye" 2012 : 2012
• 6 Yagci A, "The role and treatment of inflammation in dry eye disease" 34 : 1291-1301, 2014
• 7 Park B, "The protective effect of polygonum cuspidatum(PCE)aqueous extract in a dry eye model" 10 : 1550-, 2018
• 8 Baudouin C, "Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction" 100 : 300-306, 2016
• 9 Zheng Q, "Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients" 134 : 133-140, 2015
• 10 Yang Y, "Programmed cell death and its role in inflammation" 2 : 12-, 2015
• 11 Park B, "Polydatin Inhibits NLRP3 Inflammasome in Dry Eye Disease by Attenuating Oxidative Stress and Inhibiting the NF-κB Pathway" 11 : 2792-, 2019
• 12 Versura P, "Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases" 35 : 553-564, 2010
• 13 Reppetti J, "Osmotic stress induces apoptosis in extravillous trophoblast cells. Role of TRPV-1" 514 : 58-63, 2019
• 14 Park S, "One case of dry eye syndrome, treated with Hwanggryunhaedok-tang herbal acupuncture and chungganmyungmok-tang" 153-159, 2015
• 15 Shantha TR, "New methods of treating dry eye syndrome. US Patent App. 2012;12/828,292"
• 16 Kamel C, "Natural plant extracts : Classical remedies bring modern animal production solutions" 54 : 31-38, 2001
• 17 Kirschweng B, "Melt stabilization of PE with natural antioxidants : Comparison of rutin and quercetin" 103 : 228-237, 2018
• 18 Carović-StanKo K, "Medicinal Plants of the Family Lamiaceaeas Functional Foods–a Review" 34 : 377-, 2016
• 19 Lemp MA, "Management of dry eye disease" 14 : S88-S101, 2008
• 20 Lv WF, "Isolation and quantitation of amygdalin in Apricot-kernel and Prunus Tomentosa Thunb. by HPLC with solid-phase extraction" 43 : 383-387, 2005
• 21 Chen YT, "Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome" 177 : 1333-1343, 2010
• 22 Lemp MA, "Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort : a retrospective study" 31 : 472-478, 2012
• 23 Reitmeir P, "Common eye diseases in older adults of southern Germany : results from the KORA-Age study" 46 : 481-486, 2017
• 24 Foulks GN, "Clinical guidelines for management of dry eye associated with Sjögren disease" 13 : 118-132, 2015
• 25 Johnson ME, "Changes in the tear film and ocular surface from dry eye syndrome" 23 : 449-474, 2004
• 26 Pflugfelder SC, "Aqueous tear deficiency increases conjunctival interferon-γ(IFN-γ)expression and goblet cell loss" 56 : 7545-7550, 2015
• 27 Hsu CY, "Antioxidant activity of extract from Polygonum cuspidatum" 40 : 13-21, 2007
• 28 Zhang H, "A review of the pharmacological effects of the dried root of Polygonum cuspidatum (Hu Zhang) and its constituents" 2013 : 2013
• 29 Li J, "A mouse dry eye model induced by topical administration of the air pollutant particulate matter 10" 96 : 524-534, 2017
• 30 Hou A, "A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue" 124 : e55592-, 2017